Saturday, December 6, 2025

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Super Micro Surges to Pre-Hindenburg Levels: Stock Climbs 7.97%

Super Micro Computer's stock surged nearly 8% after a strong comeback from Hindenburg's accusations, driven by AI server demand.

Analysis: Kim’s Strategic Silence Is a Green Light for Trump’s Next Deal

Kim Jong Un declares North and South Korea as separate states, questioning unification, while focusing on agricultural achievements in recent speech.

Tag: Ceasefire

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.